The Study of Accrual to Clinical Trials: Can We Learn From Studying Who Enters Our Studies?
- 1 June 2004
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (11) , 2039-2040
- https://doi.org/10.1200/jco.2004.02.926
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment TrialsJournal of Clinical Oncology, 2002
- Racial and Ethnic Disparities in the Receipt of Cancer TreatmentJNCI Journal of the National Cancer Institute, 2002
- Minority Recruitment in the Prostate Cancer Prevention TrialAnnals of Epidemiology, 2000
- Race and Differences in Breast Cancer Survival in a Managed Care PopulationJNCI Journal of the National Cancer Institute, 1999
- National cancer clinical trials: Children have equal access; adolescents do notJournal of Adolescent Health, 1997
- Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation.Journal of Clinical Oncology, 1997
- Representation of African-Americans, Hispanics, and Whites in National Cancer Institute Cancer Treatment TrialsJNCI Journal of the National Cancer Institute, 1996
- Response to “inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 — The perspective of NIH clinical trialists”Controlled Clinical Trials, 1995
- Base-Line Quality-of-Life Assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention TrialJNCI Journal of the National Cancer Institute, 1995
- The Community Clinical Oncology Program: Its Effect on Clinical PracticeThe Joint Commission Journal on Quality Improvement, 1995